The Cigna Group (CI) FY2024 Annual P&L / Income Statement

The Cigna Group (CI) FY2024 Annual P&L / Income Statement

Income statement for 2024-01-01 through 2024-12-31. View: Product and service (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

TOTAL REVENUES

247,121,000,000 US dollars

TOTAL BENEFITS AND EXPENSES

237,704,000,000 US dollars

Income from operations

9,417,000,000 US dollars

Other income (expense), net (calculated)

negative 4,148,000,000 US dollars

Income before income taxes

5,269,000,000 US dollars

TOTAL INCOME TAXES

1,491,000,000 US dollars

Net income

3,778,000,000 US dollars

Pharmacy revenues

185,362,000,000 US dollars

Fees and other revenues

14,790,000,000 US dollars

Premiums

45,996,000,000 US dollars

Net investment income

973,000,000 US dollars

Pharmacy and other service costs

182,509,000,000 US dollars

Medical costs and other benefit expenses

38,648,000,000 US dollars

Selling, general and administrative expenses

14,844,000,000 US dollars

Amortization of acquired intangible assets

1,703,000,000 US dollars

Chart connections

• Revenue minus operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to The Cigna Group: $3.43 B; to noncontrolling interests: $344.00 M.